New research reveals that triggering a cell’s DNA damage response could be a promising avenue for developing novel treatments against several rare but devastating viruses for which no antiviral treatments exist.
The University at Buffalo has been awarded a highly competitive, $3.6 million grant from the National Institute on Minority Health and Health Disparities to train early-career faculty members to address health inequities in Western New York.
Two doctoral candidates at the Jacobs School of Medicine and Biomedical Sciences have received 2024 predoctoral fellowships with two years of funding from the American Heart Association (AHA).
The Jacobs School of Medicine and Biomedical Sciences is among the nation’s most diverse medical schools, according to the 2024-2025 America’s Best Graduate School rankings released July 23 by U.S. News & World Report.
Four UB projects spanning multiple disciplines that are using artificial intelligence to enhance health care have received interdisciplinary seed funding for AI research in health care.
Telemedicine referrals for patients with opioid use disorder (OUD) can be a more effective way than an in-person emergency department visit to get patients to start and stay with medication assisted treatment through an outpatient clinic.
Leonard E. Egede, MD, the Charles and Mary Bauer Professor and Chair of the Department of Medicine, has been honored by the National Institutes of Health (NIH) with its 2024 Robert S. Gordon Jr. Award for Epidemiology.
Allison Brashear, MD, vice president for health sciences and dean of the Jacobs School, has been appointed to the board of directors of the Association for American Medical Colleges (AAMC).
Moriah Martindale is one of just 29 medical students nationwide who were chosen to participate in the third year of the NFL Diversity in Sports Medicine Pipeline Initiative.
The National Cancer Institute has awarded a five-year, $3 million grant to Remi M. Adelaiye-Ogala, PhD, assistant professor of medicine, to continue studying treatment mechanisms of treatment resistance in advanced prostate cancers.